Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuyan Ling

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Public Health|September 29, 2025
Coping behavior toward occupational health risks among construction workers: determinant identification using the COM-B model and data mining analysisXuesong Yang, Yuyan Ling, Liqun Wang, et al.
Brain Research Bulletin|February 20, 2025
Discovery and validation of CREB1 as a transcription target of icaritin: Implications for the treatment of depressive-like behaviorLing Gu, Lei Li, Huiying Xu, et al.
Medicine in Novel Technology and Devices|August 8, 2022
Treatment of COVID-19 by monoclonal antibodies and the traditional Chinese medicineYuyan Ling, Yuxuan Dong, Qirui Li, et al.
Depression and Anxiety|December 22, 2025
MicroRNAs as Regulators of Neuroinflammation in Major Depressive DisorderQirui Li, Yuyan Ling, Ling Gu, et al.
European Journal of Pharmacology|April 28, 2025
Kumatakenin alleviates depressive-like behaviors by suppressing excessive autophagy in hippocampus via ATG5Lei Li, Ling Gu, Yang Hua, et al.
Journal of Ethnopharmacology|June 11, 2026
San Wei Tan Xiang (SWTX) ameliorates depressive-like behaviors by modulating 6-phosphogluconate dehydrogenase (6PGD) activity in miceYuyan Ling, Ling Gu, Shuxun Feng, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Public Health|September 29, 2025
Coping behavior toward occupational health risks among construction workers: determinant identification using the COM-B model and data mining analysisXuesong Yang, Yuyan Ling, Liqun Wang, et al.
Brain Research Bulletin|February 20, 2025
Discovery and validation of CREB1 as a transcription target of icaritin: Implications for the treatment of depressive-like behaviorLing Gu, Lei Li, Huiying Xu, et al.
Medicine in Novel Technology and Devices|August 8, 2022
Treatment of COVID-19 by monoclonal antibodies and the traditional Chinese medicineYuyan Ling, Yuxuan Dong, Qirui Li, et al.
Depression and Anxiety|December 22, 2025
MicroRNAs as Regulators of Neuroinflammation in Major Depressive DisorderQirui Li, Yuyan Ling, Ling Gu, et al.
European Journal of Pharmacology|April 28, 2025
Kumatakenin alleviates depressive-like behaviors by suppressing excessive autophagy in hippocampus via ATG5Lei Li, Ling Gu, Yang Hua, et al.
Journal of Ethnopharmacology|June 11, 2026
San Wei Tan Xiang (SWTX) ameliorates depressive-like behaviors by modulating 6-phosphogluconate dehydrogenase (6PGD) activity in miceYuyan Ling, Ling Gu, Shuxun Feng, et al.
Pageof 1